SAFE director adds 346 CSEs; holdings now 88,734 direct

Rhea-AI Filing Summary

Safehold Inc. (SAFE) director Form 4: On 10/15/2025, Director Robin Josephs was credited with 346 Common Stock Equivalents (CSEs) under the Non‑Employee Directors' Deferral Plan. These CSEs arise as dividends are paid and convert one‑for‑one into shares of Safehold common stock.

Following the transaction, beneficial ownership was 88,734 shares direct, 3,107 shares indirect via an IRA, and 64,696 shares indirect via a family trust.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider JOSEPHS ROBIN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	346	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 88,734 shares (Direct); Common Stock — 3,107 shares (Indirect, By IRA)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JOSEPHS ROBIN

(Last) (First) (Middle)

1114 AVENUE OF THE AMERICAS, 39TH FLR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Safehold Inc. [ SAFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		A		346	A(1)	$0	88,734	D
Common Stock								3,107	I	By IRA
Common Stock								64,696	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 15, 2025, the Reporting Person acquired 346 Common Stock Equivalents (CSEs) in accordance with the provisions of the Non-Employee Directors' Deferral Plan (Plan). Under the Plan, as dividends are declared and paid on Safehold Inc. common stock, the Reporting Person's holdings of outstanding CSEs are credited with additional CSEs based on the amount of the dividend and the value of a share of Safehold Inc. Common Stock on the dividend date. Each CSE is convertible on a one-for-one basis into shares of Safehold Inc. common stock.

	/s/ Austin Lee, as Attorney-in-Fact for Robin Josephs	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Safehold (SAFE) disclose in this Form 4?

A director received 346 CSEs on 10/15/2025 under the Non‑Employee Directors' Deferral Plan, which convert one‑for‑one into common shares.

Who is the reporting person in the SAFE Form 4?

Director Robin Josephs.

How many shares does the director beneficially own after the transaction?

88,734 direct; 3,107 indirect via IRA; 64,696 indirect via family trust.

What is a Common Stock Equivalent (CSE) at Safehold?

A CSE accrues under the director deferral plan as dividends are paid and is convertible one‑for‑one into Safehold common stock.

Was there a purchase price for the 346 CSEs?

The reported price was $0, consistent with accruals under a dividend‑based deferral plan.

Is this transaction under a Rule 10b5‑1 plan?

The form includes a checkbox reference to Rule 10b5‑1(c); the disclosed transaction reflects plan‑based accruals under the director deferral plan.